Nat. Rev. Neurol. doi: /nrneurol

Slides:

Advertisements

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Advertisements

Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Copyright © 2009 American Medical Association. All rights reserved.

Figure 3 Life expectancy at birth in all countries included

Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 4 Paradoxical immune reconstitution inflammatory syndrome

Clayton Wiley MD/PhD.

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 4 Host damage from infection-related inflammatory

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Overview of risk factors for Parkinson disease dementia

Figure 2 Systemic immune responses to cryptococcal antigen

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Proportion of patients for whom NEDA

Figure 5 Number of AHSCT procedures for

Nat. Rev. Neurol. doi: /nrneurol

Figure 5 Corticosteroid treatment can reduce brain

Figure 2 Co-stimulatory receptors as immunomodulatory targets

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Associations between baseline cerebrospinal fluid

Figure 1 Allele frequency and effect size for ALS-associated genes

Figure 3 LGI1 and Caspr2 immunohistochemistry on rat brain

Figure 2 Pathological features of opportunistic infections of the CNS

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Hypothetical mechanisms of smoking-associated

Figure 2 Algorithm for immunosuppressive treatment

Figure 1 Principles of therapeutic ultrasound

Figure 1 Clinical correlates of neurodegeneration in MS

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Genetic pleiotropy in ALS

Nat. Rev. Neurol. doi: /nrneurol

Figure 4 Lifestyle and environmental factors affect

Figure 1 Evolution of multiple sclerosis

Figure 1 The trajectory of cognitive ageing

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Anatomical patterns of neuropathy

Figure 3 Stroke-related deaths and DALYs by country development status

Figure 3 MRI findings in opportunistic infections of the CNS

Figure 2 Carotid artery inflammation detected using 68Ga-DOTATATE-PET

Figure 6 Combining population-wide and high-risk strategies

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Logistical requirements for autologous

Figure 3 Potential interplay between physiological

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Chromosomal region 15q11.2–q13

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 The VEGF family of growth factors

Figure 2 Cellular pathways implicated in CIPN

Figure 2 Pathophysiological mechanisms in LGMD

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Timing of the effects of deep brain stimulation

Figure 5 Interaction between infarction and amyloid deposition

Figure 1 A large number of genes are potentially associated with CIPN

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Rett syndrome severity and age at diagnosis by mutation type

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Craniospinal irradiation proton therapy for medulloblastoma

Figure 2 Reduced frequency of central memory CD4 T cells in patients with PML Reduced frequency of central memory CD4 T cells (CD4Tcm) (p < ), naive.

Figure 1 Evolution of MRI findings during interleukin (IL)–7 therapy

Figure 2 Histopathological features in CIDP

Figure 2 Evolution of blood cell counts during interleukin (IL)–7 therapy Evolution of blood cell counts during interleukin (IL)–7 therapy The leukocyte.

Figure 1 Peripheral blood lymphocyte counts during dose titrationB-lymphocyte (CD19+; A) and total lymphocyte (CD45+; B) counts (cells/µL) in peripheral.

Figure 4 Cell count of selective immune cell subpopulations during alemtuzumab Cell count of selective immune cell subpopulations during alemtuzumab Absolute.

Figure 4 Longitudinal analysis of peripheral immune cell composition Frequency of naive, central memory (Tcm), and effector memory (Tem) CD4 T cells over.

Presentation transcript:

Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.149 Figure 1 Level of immunosuppression and risk of opportunistic infections Figure 1 | Level of immunosuppression and risk of opportunistic infections. This figure depicts the concentration of CD4+ cells in which a given HIV-associated CNS opportunistic infection can develop (dark blue bars). Rare cases of infections reported past these limits are indicated by arrows. The light blue overlay grossly depicts the most common CD4+ cell counts for each respective opportunistic infection14,34,106,113,114,115. CMV, cytomegalovirus infection, PML, progressive multifocal leukoencephalopathy. Bowen, L. N. et al. (2016) HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.149